Michael Sawyer led a research team that has discovered a new method for the early detection of pancreatic cancer.
Pancreatic cancer has a dismal prognosis, especially if it is diagnosed late. But a new non-invasive way of detecting the disease early offers the potential for more treatment options, say Edmonton researchers. The scientific team, led by Department of Oncology researcher Michael Sawyer , found that by using metabolomics-the unique chemical fingerprints that cellular processes leave behind-to detect pancreatic cancer at an early stage may facilitate the discovery of novel pancreatic cancer biomarkers. The article was published in the Annals of Surgical Oncology . "We were surprised at how good these results were,” said Sawyer, an Alberta Health Services medical oncologist at the Cross Cancer Institute. "Pancreatic cancer is incredibly hard to detect, and symptoms are very vague. This method did a good job of discriminating between people with cancer and those without.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
